A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...

The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' cell therapy for a rare form of ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...

Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...